Fiona Bisshop
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine.
Journal: Sexual health
Published: February 05, 2026
"Ever since I knew I was trans I knew I wanted hormone therapy": a qualitative exploration into the journey of Australian trans individuals accessing feminizing gender-affirming hormone therapy.
Journal: International journal of transgender health
Published: October 28, 2024
Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! Audit.
Journal: International journal of transgender health
Published: October 28, 2024
One person, many changes: a socioecological qualitative analysis of the experiences of transfeminine individuals undergoing feminising gender-affirming hormone therapy.
Journal: Culture, health & sexuality
Published: June 03, 2024
How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones.
Journal: International journal of transgender health
Published: February 20, 2024
Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis.
Journal: Open forum infectious diseases
Published: February 14, 2024
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.
Journal: HIV medicine
Published: December 12, 2023
Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 28, 2023
Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs: The PUSH! Audit.
Journal: Australian journal of general practice
Published: April 06, 2023
Highs, Lows, and Hormones: A Qualitative Metasynthesis of Transgender Individuals' Experiences Undergoing Gender-Affirming Hormone Therapy.
Journal: Journal of homosexuality
Published: March 08, 2023
Re: The RANZCP position statement on gender dysphoria.
Journal: The Australian and New Zealand journal of psychiatry
Published: July 11, 2022
What you need to know about gender-affirming healthcare.
Journal: Emergency medicine Australasia : EMA
Published: April 09, 2022
Last Updated: 09/26/2026